Global Hemodynamic Monitoring Market Size (2024 - 2029)

The hemodynamic monitoring systems market is projected to experience growth over the forecast period, driven by factors such as the increasing prevalence of cardiac disorders and diabetes, a rise in critically ill geriatric cases, and a growing demand for home-based and non-invasive monitoring systems. The market's expansion is further supported by advancements in monitoring techniques that enhance patient management during postoperative care and anesthesia. However, challenges such as complications from invasive monitoring systems and stringent regulatory requirements may impede market growth.

Market Size of Global Hemodynamic Monitoring Industry

Hemodynamic Monitoring Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 1.24 Billion
Market Size (2029) USD 1.48 Billion
CAGR (2024 - 2029) 3.58 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Hemodynamic Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Hemodynamic Monitoring Devices Market Analysis

The Global Hemodynamic Monitoring Market size is estimated at USD 1.24 billion in 2024, and is expected to reach USD 1.48 billion by 2029, growing at a CAGR of 3.58% during the forecast period (2024-2029).

COVID-19 has a substantial market impact. According to the LiDCO Group PLC's annual report for 2020, demand for hemodynamic monitoring equipment has increased from many existing customers, with significant short-term heightened demand from UK hospitals and increased demand in several other countries, including a small number of monitors sold in Wuhan, China. Furthermore, some COVID-19 patients develop complications such as sepsis and require intensive care, and there is strong clinical evidence that using advanced hemodynamic monitoring improves patient outcomes. Hence, this is also likely to create more demand for the products till the pandemic ends.

The key factors propelling the growth of this market are an increase in the number of critically ill geriatric cases, a rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, and an increase in the number of people suffering from hypertension. As per the World Health Organization's Fact of 2021, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension. As per the same source, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year, an estimated 32% of all the deaths worldwide. Hence the prevalence of cardiac disorders and hypertension will likely boost the market growth.

New techniques of hemodynamic monitoring have the potential to advance the management of the cardiovascular patient during postoperative care and anesthesia as they provide accurate and repeatable measurements that can be used to detect hemodynamic alterations and their causes, optimize hemodynamic conditions such as oxygen delivery to the tissues, and provide feedback on the adequacy of therapeutic interventions. The transition from static to dynamic variables to assess requirements such as cardiac preload and fluid responsiveness, as well as the change to less invasive or noninvasive monitoring techniques, are also driving the market growth.

Thus, the market is expected to show growth over the forecast period. However, Increasing incidences of complications associated with an invasive monitoring system and stringent FDA guidelines for approval of new systems may hinder the growth of the market.

Hemodynamic Monitoring Devices Industry Segmentation

As per the report's scope, critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, also known as hemodynamic systems. The primary function of these systems is to monitor cardiac activity. The hemodynamic systems give blood pressure, volume, and fluid balance information. The Hemodynamic Monitoring Market is Segmented by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, and Non-invasive Monitoring Systems), Application (Laboratory-based Monitoring Systems, Home-based Monitoring Systems, Hospital-based Monitoring Systems), and, Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.

By System
Minimally Invasive Monitoring Systems
Invasive Monitoring Systems
Non-invasive Monitoring Systems
By Application
Laboratory-based Monitoring Systems
Home-based Monitoring Systems
Hospital-based Monitoring Systems
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Hemodynamic Monitoring Market Size Summary

The hemodynamic monitoring systems market is poised for growth, driven by an increasing prevalence of critically ill geriatric cases, cardiac disorders, and diabetes. The demand for home-based and non-invasive monitoring systems is also on the rise, fueled by the growing number of individuals suffering from hypertension. The transition from static to dynamic variables in monitoring techniques, along with advancements in minimally invasive systems, is enhancing the accuracy and effectiveness of hemodynamic assessments. These developments are expected to propel market expansion over the forecast period, despite challenges such as complications associated with invasive monitoring systems and stringent regulatory approvals.

North America currently leads the hemodynamic monitoring market, with the United States holding a significant share due to its technologically advanced healthcare infrastructure and the presence of major market players. The region's growth is supported by increasing FDA approvals for monitoring devices and new product launches. The competitive landscape is characterized by the dominance of key players like Getinge Group, Koninklijke Philips NV, and Edwards Lifesciences Corporation, while mid-size and smaller companies are gaining traction through technological innovations and cost-effective solutions. These dynamics are anticipated to sustain the market's growth trajectory in the coming years.

Explore More

Global Hemodynamic Monitoring Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Critically Ill Geriatric Population

      2. 1.2.2 Rise in the Prevalence of Cardiac Disorders and Diabetes

      3. 1.2.3 Technological Advanements

    3. 1.3 Market Restraints

      1. 1.3.1 Increasing Incidences of Complications Associated with Invasive Monitoring Systems

      2. 1.3.2 Stringent FDA Guidelines for Approval of New Systems

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By System

      1. 2.1.1 Minimally Invasive Monitoring Systems

      2. 2.1.2 Invasive Monitoring Systems

      3. 2.1.3 Non-invasive Monitoring Systems

    2. 2.2 By Application

      1. 2.2.1 Laboratory-based Monitoring Systems

      2. 2.2.2 Home-based Monitoring Systems

      3. 2.2.3 Hospital-based Monitoring Systems

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Hemodynamic Monitoring Market Size FAQs

The Global Hemodynamic Monitoring Market size is expected to reach USD 1.24 billion in 2024 and grow at a CAGR of 3.58% to reach USD 1.48 billion by 2029.

In 2024, the Global Hemodynamic Monitoring Market size is expected to reach USD 1.24 billion.

Hemodynamic Monitoring Systems Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)